" class="no-js "lang="en-US"> SomaLogic Archives - Medtech Alert
Saturday, June 10, 2023

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

SomaLogic Announces License Agreement with OncoHost for the Development of Precision Cancer Diagnostics

SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced it has signed a […]

Major Journal Publishes Landmark Proteomics Study Demonstrating Development of an Unprecedented New Clinical Cardiovascular Risk Test

In one of the largest proteomic studies ever conducted and published April 6 in the […]

SomaLogic to Provide 210 Million Protein Measurements to EPIC Researchers to Better Understand and Predict Cancer Development

SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced that the company will […]

SomaLogic Announces Appointment of Adam Taich as Chief Business Officer

SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced that Adam Taich has […]

SomaLogic Announces Exclusive Partnership with Illumina to Develop Sequencing-based Proteomic Solutions

SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a worldwide strategic collaboration […]

SomaLogic Announces Strategic Collaboration with University Hospitals Cleveland Medical Center to Treat Diabetic Patients at High Risk of Cardiovascular Disease

SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a strategic collaboration with […]

SomaLogic Expands Leadership Team with New Positions to Drive Commercial Success

CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, a leader in AI data-driven proteomics technology, […]

SomaLogic Announces Appointment of Shaun Blakeman as Chief Financial Officer

CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, a leader in AI-data driven proteomics technology, […]

Ixaka and SomaLogic Enter Research Collaboration to Develop Bispecific Agents for Oncology

Ixaka Ltd and SomaLogic today announce a research collaboration to support the development of aptamer-based […]

  1. Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration Read more
  2. Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease Read more
  3. Genmab Showcases Data From Comprehensive Epcoritamab Development Program in Patients Across B-Cell Lymphomas Read more
  4. Quell Therapeutics Signs Agreement with AstraZeneca to Develop and Commercialize Engineered Treg Cell Therapies for Autoimmune Diseases Read more
  5. Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430 Read more